Home > Insider Trading > Filing (0001209191-16-123070)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1340652	Chemocentryx Inc.	CCXI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1324991	L James Tyree	C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-21	11,795	$0.00	26,119	No	4	M	Direct
Common Stock	Disposition	2016-05-23	5,544	$4.39	20,575	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2016-05-21	11,795	$0.00	11,795	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Shares were acquired upon vesting of restricted stock units awarded on May 21, 2015.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover estimated taxes due upon vesting of restricted stock units.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $4.25 to $4.59 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
100% of the restricted stock units vested on May 21, 2016. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.